New Canon Digital Radiography Systems to be Showcased at RSNA Annual Meeting, Highlighting Ergonomic Design
Canon U.S.A. also announces new version of software to streamline workflow for Canon detectors MELVILLE, N.Y., Nov. 22, 2017 -- (Healthcare Sales &Marketing Network) -- Leveraging the rich history of high-quality imaging and innovation of its parent c... Devices, Radiology, Product Launch Canon, CXDI, digital radiography
Publication date: Available online 12 November 2018Source: The Veterinary JournalAuthor(s): U. Bartoszuk, B.W. Keene, M.B. Toaldo, N. Pereira, N. Summerfield, J.N. Matos, T.M. GlausAbstractArrhythmias can complicate cardiac disease in cats and are a potential cause of sudden death. The aim of this study was to evaluate the presence and nature of cardiac arrhythmias, and the potential correlation between plasma serum troponin I (cTnI) concentrations and the presence or severity of arrhythmias in cats with decompensated (dHCM) and compensated hypertrophic cardiomyopathy (cHCM). Forty one client-owned cats were studied: 16 wi...
Agfa HealthCare will present its digital radiography (DR) tomosynthesis technology...Read more on AuntMinnie.comRelated Reading: Agfa, PACSHealth to install dose software at VA network Agfa wins DR 800 orders from Florida Hospital Agfa prepares to show updated Musica workstation at RSNA 2018 Agfa-Gevaert declines buyout offer from Kanteron Agfa completes South Carolina PACS project
GE could put a bigger stake of its GE Healthcare division on the market than...Read more on AuntMinnie.comRelated Reading: U.K., Perspectum, GE invest in liver software GE Healthcare posts flat Q3 revenue but profits edge up Fate of the 4: 2018 progress report for GE, Siemens, Canon, and Philips GE brings Invenia 2.0 ultrasound to U.S. GE partners on radiographer training in Kenya
Conclusion: Our analysis provides a rationale for the routine use of a radiopaque tissue transfer system for specimen radiography in BCS after neoadjuvant chemotherapy for invasive breast cancer in order to reduce re-excision rates.Breast Care
AbstractBackgroundRoughly 23% of breast conserving surgery (BCS) patients undergo a second re-excision procedure due to pathologically positive surgical margins. We investigated the feasibility and potential value of micro-Computed Tomography (micro-CT) as a surgical margin guidance tool during BCS.MethodsA cohort of 32 BCS specimens was prospectively imaged with a pre-clinical micro-CT system upon arrival in the surgical pathology laboratory. Reconstructed micro-CT scans were evaluated retrospectively by an experienced breast radiologist, who provided binary determinations whether lesions extended to the specimen margin. ...
ConclusionParents did not feel adequately informed prior to their child ’s radiographic examination. Parents expect more information about the purpose, dose and alternative tests.
AbstractBackgroundThe lateral opening wedge distal femoral osteotomy (LOWDFO) to reconstruct knee alignment in patients with genu valgum originating in the distal femur has gained importance within the last years.PurposeTo analyze clinical and radiographic outcome of patients treated with LOWDFO with respect to bone healing without grafting and patient age.Material and methodsTwenty-two consecutive patients with genu valgum corrected with 23 LOWDFOs using a Tomofix-locking plate were retrospectively analyzed (mean age 23.7 years). Clinical evaluation was based on pre- and post-operative KOOS scores. A pre- and post-o...
ConclusionThe current study did not find evidence of an influence of osteoarthritis on PTA or on the repeatability of measurements.Clinical significanceOur findings suggest that osteoarthritis should not affect the radiographic planning for tibial tuberosity advancement surgery. The high variances in PTA measurement in less experienced observers may influence the clinical outcome of surgery.
ConclusionIrrespective of sex and ethnicity, metacarpal growth was similar to that of the non-weight-bearing radius but differed from that of the weight-bearing tibia. The local and systemic factors influencing site-specific differences require further investigation.Graphical abstractᅟ
ConclusionsHBOT is safe and well-tolerated in pediatric and young adult patients with CNS tumors. Clinical and radiographic improvements were observed in over half of patients. Clinical trials are needed to establish safety and efficacy of HBOT as adjunct therapy in pediatric CNS tumors.